Clinical Study
Magnetic Resonance Imaging Evaluation in Patients with Linear Morphea Treated with Methotrexate and High-Dose Corticosteroid
Table 2
The association between MRI and mLoSSI and LoSDI.
| Variables | Before treatment | P-value | After treatment | P-value |
| Erythema | 0.479 | 0.008 | 0.467 | 0.008 |
| Skin thickness | 0.345 | 0.053 | 0.466 | 0.008 |
| New lesion/lesion extension | 0.451 | 0.009 | 0.322 | 0.068 |
| Dermal atrophy | 0.528 | 0.004 | 0.558 | 0.002 |
| Subcutaneous atrophy | 0.642 | <0.001 | 0.585 | <0.001 |
| Dyspigmentation | 0.536 | 0.002 | 0.596 | <0.001 |
|
|
correlation coefficient with MRI scores is shown in these columns. P-values are adjusted by Benjamini and Hochberg method. |